ABBV-8736
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABBV-8736, covering 2026-02-23 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers [Phase 1]